3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
7
Prostatic Neoplasms
4
Precancerous Conditions
2
Neoplasms
2
Weight Loss
1
Uterine Cervical Neoplasms
1
Radiation Injuries
1
Psoriasis
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Pelvic Inflammatory Disease
1
Pain
1
Ovarian Neoplasms
1
Osteoarthritis
1
Fatigue
1
Esophageal Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthralgia
1
Interventions
Adalimumab
2
Vitamin D
1
Syringes
1
Sodium Chloride
1
Lysine Acetyltransferase 5
1
Injections
1
Holistic Health
1
High-Intensity Interval Training
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
Calcitriol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Arthritis, Rheumatoid
×
Fatty Acids, Omega-3
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts